Primary cutaneous B-cell lymphomas

H M Prince; L M Yap; R Blum; C McCormack

doi:10.1046/j.1365-2230.2003.01170.x

Primary cutaneous B-cell lymphomas

Clin Exp Dermatol. 2003 Jan;28(1):8-12. doi: 10.1046/j.1365-2230.2003.01170.x.

Authors

H M Prince¹, L M Yap, R Blum, C McCormack

Affiliation

¹ Division of Haematology and Medical Oncology, Peter MacCallum Cancer Institute, Melbourne, Victoria, Australia. [email protected]

PMID: 12558619
DOI: 10.1046/j.1365-2230.2003.01170.x

Abstract

B-cell lymphomas comprise up to 25% of primary cutaneous non-Hodgkin lymphoma (NHL). Two main classification systems are used, namely the European Organization for Research and Treatment of Cancer (EORTC) and the World Health Organization (WHO) classification of tumours. Indeed, there is much controversy surrounding which classification system to use, which in turn influences the interpretation of existing data and subsequently how we manage patients with these conditions.

Publication types

Review

MeSH terms

Humans
Lymphoma, B-Cell / classification
Lymphoma, B-Cell / pathology*
Lymphoma, B-Cell / therapy
Lymphoma, Follicular / classification
Lymphoma, Follicular / pathology
Lymphoma, Large B-Cell, Diffuse / classification
Lymphoma, Large B-Cell, Diffuse / pathology
Lymphoma, Non-Hodgkin / classification
Lymphoma, Non-Hodgkin / pathology
Pseudolymphoma / pathology
Skin Neoplasms / classification
Skin Neoplasms / pathology*
Skin Neoplasms / therapy
Terminology as Topic
Treatment Outcome